EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, the company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman, and headquarters in West Palm Beach, FL. The latest investment, a $41.00M Series B investment, took place on 21 December 2021 and was led by Americo Financial Life and Annuity. Their focus on Big Data, Biotechnology, and Health Care indicates their innovative approach to revolutionizing cancer treatment. With their strategic positioning and strong financial backing, EXUMA Biotech is poised for continued growth and impact in the biotechnology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $41.00M | 1 |
|
21 Dec 2021 |
| Series B | $19.00M | 2 |
|
12 Mar 2020 |
| Venture Round | $10.00M | 1 |
|
08 Jan 2018 |
| Series A | $37.00M | 4 |
|
16 Feb 2017 |
No recent news or press coverage available for EXUMA Biotech.
We care about your data, and we'd love to use cookies make your experience better.
